Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-9-9
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-9683
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-60
|
pubmed:dateRevised |
2009-2-13
|
pubmed:meshHeading |
pubmed-meshheading:3113349-Coronary Disease,
pubmed-meshheading:3113349-Ethics, Medical,
pubmed-meshheading:3113349-Health Expenditures,
pubmed-meshheading:3113349-Humans,
pubmed-meshheading:3113349-Life Expectancy,
pubmed-meshheading:3113349-Myocardial Infarction,
pubmed-meshheading:3113349-Myocardial Revascularization,
pubmed-meshheading:3113349-Quality of Life,
pubmed-meshheading:3113349-Risk
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Extend or restrict the indications for myocardial revascularization?].
|
pubmed:publicationType |
Journal Article
|